Annual ROE
-98.96%
-49.19%-98.83%
December 31, 2021
Summary
- As of February 10, 2025, GBT annual return on equity is -98.96%, with the most recent change of -49.19% (-98.83%) on December 31, 2021.
- During the last 3 years, GBT annual ROE has fallen by -68.55% (-225.42%).
Performance
GBT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-150.28%
-32.81%-27.93%
June 30, 2022
Summary
- As of February 10, 2025, GBT quarterly return on equity is -150.28%, with the most recent change of -32.81% (-27.93%) on June 30, 2022.
- Over the past year, GBT quarterly ROE has dropped by -85.31% (-131.31%).
Performance
GBT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
GBT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -98.8% | -131.3% |
| 3 y3 years | -225.4% | -336.4% |
| 5 y5 years | -169.6% | -286.1% |
GBT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +58.6% | at low |
| 5 y | 5-year | +113.6% | at low | +251.8% | at low |
| alltime | all time | -241.9% | at low | -111.6% | +15.0% |
Global Blood Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -150.28%(+27.9%) |
| Mar 2022 | - | -117.47%(+24.0%) |
| Dec 2021 | -98.96%(+98.8%) | -94.73%(+27.2%) |
| Sep 2021 | - | -74.50%(+14.7%) |
| Jun 2021 | - | -64.97%(+17.5%) |
| Mar 2021 | - | -55.28%(+10.4%) |
| Dec 2020 | -49.77%(+7.4%) | -50.07%(-3.5%) |
| Sep 2020 | - | -51.90%(+2.2%) |
| Jun 2020 | - | -50.77%(+7.5%) |
| Mar 2020 | - | -47.21%(+10.5%) |
| Dec 2019 | -46.33%(+52.4%) | -42.72%(+21.0%) |
| Sep 2019 | - | -35.32%(+2.6%) |
| Jun 2019 | - | -34.44%(-0.0%) |
| Mar 2019 | - | -34.45%(+3.3%) |
| Dec 2018 | -30.41% | -33.35%(-7.9%) |
| Sep 2018 | - | -36.23%(-3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | -37.43%(-3.4%) |
| Mar 2018 | - | -38.74%(-3.9%) |
| Dec 2017 | -36.71%(-17.1%) | -40.31%(+0.7%) |
| Sep 2017 | - | -40.04%(+2.9%) |
| Jun 2017 | - | -38.92%(+0.5%) |
| Mar 2017 | - | -38.73%(-12.5%) |
| Dec 2016 | -44.26%(+34.4%) | -44.28%(+9.3%) |
| Sep 2016 | - | -40.52%(+1.0%) |
| Jun 2016 | - | -40.13%(-36.0%) |
| Mar 2016 | - | -62.75%(-7.4%) |
| Dec 2015 | -32.93%(-178.1%) | -67.76%(-60.8%) |
| Sep 2015 | - | -172.75%(-254.6%) |
| Jun 2015 | - | 111.76%(-91.3%) |
| Mar 2015 | - | 1291.45%(+2961.8%) |
| Dec 2014 | 42.18%(-39.5%) | 42.18% |
| Dec 2013 | 69.75% | - |
FAQ
- What is Global Blood Therapeutics annual return on equity?
- What is the all time high annual ROE for Global Blood Therapeutics?
- What is Global Blood Therapeutics annual ROE year-on-year change?
- What is Global Blood Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Global Blood Therapeutics?
- What is Global Blood Therapeutics quarterly ROE year-on-year change?
What is Global Blood Therapeutics annual return on equity?
The current annual ROE of GBT is -98.96%
What is the all time high annual ROE for Global Blood Therapeutics?
Global Blood Therapeutics all-time high annual return on equity is 69.75%
What is Global Blood Therapeutics annual ROE year-on-year change?
Over the past year, GBT annual return on equity has changed by -49.19% (-98.83%)
What is Global Blood Therapeutics quarterly return on equity?
The current quarterly ROE of GBT is -150.28%
What is the all time high quarterly ROE for Global Blood Therapeutics?
Global Blood Therapeutics all-time high quarterly return on equity is 1291.45%
What is Global Blood Therapeutics quarterly ROE year-on-year change?
Over the past year, GBT quarterly return on equity has changed by -85.31% (-131.31%)